| Product Code: ETC6751538 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
China import shipments of pregabalin in 2024 saw significant contributions from top exporting countries such as Ireland, Indonesia, UK, India, and Metropolitan France. Despite the high concentration levels indicated by the Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) for 2020-2024 was -6.23%. However, there was a marginal improvement in the growth rate from 2023 to 2024, standing at 0.01%. This data suggests a stable market for pregabalin imports in China, with key players continuing to play a crucial role in meeting demand.

| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 China Pregabalin Market Overview | 
| 3.1 China Country Macro Economic Indicators | 
| 3.2 China Pregabalin Market Revenues & Volume, 2021 & 2031F | 
| 3.3 China Pregabalin Market - Industry Life Cycle | 
| 3.4 China Pregabalin Market - Porter's Five Forces | 
| 3.5 China Pregabalin Market Revenues & Volume Share, By Application, 2021 & 2031F | 
| 3.6 China Pregabalin Market Revenues & Volume Share, By Drug Class, 2021 & 2031F | 
| 3.7 China Pregabalin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F | 
| 4 China Pregabalin Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 Increasing prevalence of chronic pain conditions in China | 
| 4.2.2 Growing awareness and acceptance of pregabalin for neuropathic pain management | 
| 4.2.3 Rising healthcare expenditure and improving access to healthcare services in China | 
| 4.3 Market Restraints | 
| 4.3.1 Stringent regulatory requirements for drug approval and marketing | 
| 4.3.2 Presence of generic alternatives leading to price competition | 
| 4.3.3 Concerns regarding potential side effects and misuse of pregabalin | 
| 5 China Pregabalin Market Trends | 
| 6 China Pregabalin Market, By Types | 
| 6.1 China Pregabalin Market, By Application | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 China Pregabalin Market Revenues & Volume, By Application, 2021- 2031F | 
| 6.1.3 China Pregabalin Market Revenues & Volume, By Epilepsy, 2021- 2031F | 
| 6.1.4 China Pregabalin Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F | 
| 6.1.5 China Pregabalin Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F | 
| 6.1.6 China Pregabalin Market Revenues & Volume, By Others, 2021- 2031F | 
| 6.2 China Pregabalin Market, By Drug Class | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 China Pregabalin Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F | 
| 6.2.3 China Pregabalin Market Revenues & Volume, By Anticonvulsants, 2021- 2031F | 
| 6.2.4 China Pregabalin Market Revenues & Volume, By Others, 2021- 2031F | 
| 6.3 China Pregabalin Market, By Distribution Channel | 
| 6.3.1 Overview and Analysis | 
| 6.3.2 China Pregabalin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F | 
| 6.3.3 China Pregabalin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F | 
| 6.3.4 China Pregabalin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F | 
| 6.3.5 China Pregabalin Market Revenues & Volume, By Others, 2021- 2031F | 
| 7 China Pregabalin Market Import-Export Trade Statistics | 
| 7.1 China Pregabalin Market Export to Major Countries | 
| 7.2 China Pregabalin Market Imports from Major Countries | 
| 8 China Pregabalin Market Key Performance Indicators | 
| 8.1 Prescription rates of pregabalin by healthcare providers in China | 
| 8.2 Patient satisfaction and reported pain relief with pregabalin treatment | 
| 8.3 Number of clinical trials and research studies conducted on pregabalin efficacy and safety in China | 
| 9 China Pregabalin Market - Opportunity Assessment | 
| 9.1 China Pregabalin Market Opportunity Assessment, By Application, 2021 & 2031F | 
| 9.2 China Pregabalin Market Opportunity Assessment, By Drug Class, 2021 & 2031F | 
| 9.3 China Pregabalin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F | 
| 10 China Pregabalin Market - Competitive Landscape | 
| 10.1 China Pregabalin Market Revenue Share, By Companies, 2024 | 
| 10.2 China Pregabalin Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |